点击注册小程序 查看完整报告 特别申明： 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体形势下研究 信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿订阅、接收或使用本订阅号中的任何信息。本订阅号 难以设置访问权限，若给您造成不便，敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相 关人员为光大证券的客户。 报告摘要 事件： 公司发布2025年半年度报告，2025年上半年公司实现营业收入559.6亿元，同比-13.6%；实现归母净利润 2.3亿元，同比-47.3%。其中Q2单季度公司实现营收287.9亿元，同比-13.0%，环比+6.0%；实现归母净利 润1.75亿元，同比+953.9%，环比+240.2%。 点评： 炼油、长丝价差改善，2025年Q2业绩回暖 2025年Q2，布伦特原油均价66.76美元/桶，同比-22%，环比-11%；石脑油裂解价差-50美元/吨，同比+19 美元/吨，环比+20美元/吨；炼油价差1111元/吨，同比+420元/吨，环比+158元/吨；PX价差-389元/吨，同 比-821元/吨，环比+175元/吨；PT ...

Core Viewpoint - Hengyi Petrochemical reported a total revenue of 55.96 billion yuan and a net profit of 227 million yuan for the first half of 2025, with ongoing projects expected to strengthen its position as a leading integrated enterprise in the "refining-chemical-fiber" industry chain [2] Group 1: Financial Performance - In the first half of 2025, Hengyi Petrochemical achieved total revenue of 55.96 billion yuan and a net profit attributable to shareholders of 227 million yuan [2] - The company has established a refining capacity of 8 million tons per year, PTA capacity of 21.5 million tons per year, and polymer capacity of 13.25 million tons per year [2] Group 2: R&D and Innovation - Hengyi Petrochemical increased its R&D expenditure to 460 million yuan in the first half of 2025, representing a year-on-year growth of 23.97%, and submitted 300 invention patent applications during the reporting period [3] - The company holds 566 effective patents, including 500 R&D patents and 66 smart manufacturing patents, and has participated in the formulation and revision of 58 standards [3] Group 3: Market Position and Projects - The Brunei refining project, with a capacity of 8 million tons per year, is the largest single investment project by a private Chinese enterprise overseas [4] - The ASEAN region is expected to maintain a GDP growth rate of 4.5%, which is higher than the global average, potentially driving demand for refining products [4] - Hengyi Petrochemical's integrated project for producing 120,000 tons of caprolactam and polyamide is expected to commence production in the second half of 2025 [4]

Core Viewpoint - Hengyi Petrochemical reported a total operating revenue of 55.96 billion yuan and a net profit attributable to shareholders of 0.227 billion yuan for the first half of 2025, highlighting the steady progress of its Brunei refining project and the 1.2 million tons caprolactam-polyamide project in Guangxi, which are expected to strengthen its position as a global leader in the integrated "refining-chemical-fiber" industry chain [1] Group 1: Financial Performance - In the first half of 2025, Hengyi Petrochemical achieved total operating revenue of 55.96 billion yuan and a net profit of 0.227 billion yuan [1] - The company has established a refining design capacity of 8 million tons per year, 21.5 million tons per year of PTA capacity, and 13.25 million tons per year of polymerization capacity [1] Group 2: Research and Development - Hengyi Petrochemical increased its R&D expenditure to 460 million yuan in the first half of 2025, a year-on-year increase of 23.97%, and submitted 300 invention patent applications during the reporting period [2] - As of June 30, 2025, the company holds 566 effective patents, including 500 R&D patents and 66 intelligent manufacturing patents [2] Group 3: Product Development and Market Position - The company is optimizing its polyester product structure, with differentiated fiber products accounting for 27% of its total production in the first half of 2025, leading the industry in differentiation [2] - Hengyi Petrochemical is focusing on the large-scale application of biodegradable fibers and high-value differentiated products, establishing multiple core patent technologies in areas such as ultra-cotton-like polyester fibers and transparent nylon materials [2] Group 4: Strategic Projects and Market Outlook - The Brunei refining project, with a capacity of 8 million tons per year, is the largest single investment project by a private Chinese enterprise overseas [3] - The ASEAN region is expected to maintain a GDP growth rate of 4.5% in 2025, which is higher than the global average, potentially driving demand for refining products [3] - The caprolactam-polyamide integrated project is expected to commence production in the second half of 2025 [3]

8月18日晚，恒逸石化（000703）披露2025年半年报，报告显示2025年上半年实现营业总收入559.60亿 元，归母净利润2.27亿元。值得一提的是，恒逸石化文莱炼化项目及广西120万吨己内酰胺-聚酰胺项目 稳健推进，有望进一步巩固公司作为全球领先的"炼油—化工—化纤"全产业链一体化龙头企业地位。 值得一提的是，恒逸石化近年来重点打造的年产120万吨己内酰胺—聚酰胺产业一体化项目也迎来关键 进展，项目一期预计将于下半年投产，该项目拥有技术优势、一体化优势、产品结构优势等。 恒逸石化表示，该项目投产后，将有效强化恒逸石化"一滴油，两根丝"的产业链优势，通过成本优化与 客户网络协同进一步扩大市场份额，将成为恒逸石化未来业绩增长的重要引擎。站在新一轮成长周期的 起点，恒逸石化将凭借广西钦州项目投产增厚公司业绩，文莱项目持续受益于东南亚区域供需偏紧格 局，聚酯行业景气度向好发展，有望共同勾勒出公司在未来发展的高质量增长曲线。 此外，恒逸石化持续优化聚酯产品结构，重点推广差异化长丝产品。2025年上半年，公司彩色丝、全消 光、阳离子等差别化纤维产量占比已提升至27%，差异化比例处于行业领先水平。同时，恒逸石化加速 ...

证券代码：000703 证券简称：恒逸石化 恒逸石化股份有限公司投资者关系活动记录表 编号：20250514 | | 特定对象调研 分析师会议 | | --- | --- | | 投资者关系 | 媒体采访  业绩说明会 | | 活动类别 | 新闻发布会 路演活动 | | | 现场参观 | | | 其他 （请文字说明其他活动内容） | | 参与单位名称 | 参与公司 年年度网上业绩说明会的投资者 2024 | | 及人员姓名 | | | 时间 | 年 月 2025 5 14 日，15：00—17：00 | | 地点 | 全景网"投资者关系互动平台"（http://ir.p5w.net） | | 上市公司接待 | 董事长、总裁：邱奕博 | | 人员姓名 | 副总裁、董事会秘书、财务总监：郑新刚 | | | 公司于 年 月 日 2025 5 14 15:00-17:00 在全景网"全景•路 | | | 演天下"（http://rs.p5w.net）举行 2024 年年度网上业绩说明 | | | 会。本次业绩说明会采用网络远程的方式举行，问答环节主 | | | 要内容如下： | | | 1、领导，您好 ...